Indian stock markets experienced significant declines on Wednesday. Escalating Iran-US tensions and tariff threats spooked investors, causi...

US President Donald Trump threatened steep tariffs on generic drugmakers. He stated medicines must be manufactured locally or face signific...

Donald Trump's announcement of tariffs of up to 200% on pharmaceutical imports triggered a selloff in Indian pharma stocks. However, analys...

Donald Trump's proposed up to 200% tariff on generic drug imports has raised concerns for Indian pharma companies, but industry experts say...

US President Donald Trump's proposed tariffs of up to 200% on imported generic medicines could put pressure on India's pharmaceutical expor...

President Donald Trump has given generic drugmakers two years to shift manufacturing to the US or face 100% import tariffs from August 2028...

India's gem and jewellery exports saw a significant rebound in June, increasing by 26.5 percent. Lower international gold prices and improv...

The United States is set to implement a phased approach to tariffs on generic drug imports, beginning at zero percent and escalating to one...

For Indian exporters, the two-year tariff-free period offers additional time to reassess supply chains and investment plans. While the imme...

Pharma stocks, including Sun Pharma, Cipla, Lupin and Dr Reddy's, fell up to 2.5% after US President Donald Trump announced a phased tariff...

Donald Trump is likely planning new import duties on many nations by Friday. These levies aim to continue his tariff regime after current o...

Asian stocks climbed for a second day, led by chipmakers. The Kospi Index saw a significant jump, reflecting AI investment optimism. Crude ...

Natco Pharma shares rose sharply on Monday after the U.S. FDA granted tentative approval for its generic Olaparib tablets, a bioequivalent ...

The U.S. FDA has approved Merck's new cholesterol-lowering pill, Lipfendra. This oral medication works by blocking the PCSK9 protein, which...

Eli Lilly will acquire AtaiBeckley for up to $3.8 billion. This deal aims to develop psychedelic treatments for depression and other mental...

Samsung Electronics denied exploring a U.S. listing of American Depositary Receipts. Bloomberg News had reported preliminary discussions wi...

European shares fell at the open as escalating US-Iran tensions dented risk appetite, while investors assessed earnings from BP, Ericsson a...